Christopher M Verdier
Examiner (ID: 1476, Phone: (571)272-4824 , Office: P/3745 )
Most Active Art Unit | 3745 |
Art Unit(s) | 3401, 2851, 3745, 2899 |
Total Applications | 2960 |
Issued Applications | 2317 |
Pending Applications | 150 |
Abandoned Applications | 493 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 11596784
[patent_doc_number] => 09643935
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-09
[patent_title] => 'Process for preparing 4,6-BIS (aryloxy) pyrimidine derivatives'
[patent_app_type] => utility
[patent_app_number] => 14/893666
[patent_app_country] => US
[patent_app_date] => 2014-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10525
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14893666
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/893666 | Process for preparing 4,6-BIS (aryloxy) pyrimidine derivatives | May 26, 2014 | Issued |
Array
(
[id] => 9721258
[patent_doc_number] => 20140256959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-11
[patent_title] => 'PROCESS FOR PREPARATION OF SUBSTANTIALLY PURE FOSAMPRENAVIR CALCIUM AND ITS INTERMEDIATES'
[patent_app_type] => utility
[patent_app_number] => 14/285810
[patent_app_country] => US
[patent_app_date] => 2014-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2502
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14285810
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/285810 | Process for preparation of substantially pure fosamprenavir calcium and its intermediates | May 22, 2014 | Issued |
Array
(
[id] => 11237404
[patent_doc_number] => 09464038
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-11
[patent_title] => 'Method for producing specific oximes and oximethers'
[patent_app_type] => utility
[patent_app_number] => 14/892114
[patent_app_country] => US
[patent_app_date] => 2014-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6205
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14892114
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/892114 | Method for producing specific oximes and oximethers | May 19, 2014 | Issued |
Array
(
[id] => 9721263
[patent_doc_number] => 20140256964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-11
[patent_title] => 'OXIDATION PROCESS TO PRODUCE A CRUDE DRY CARBOXYLIC ACID PRODUCT'
[patent_app_type] => utility
[patent_app_number] => 14/282360
[patent_app_country] => US
[patent_app_date] => 2014-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9427
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14282360
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/282360 | Oxidation process to produce a crude dry carboxylic acid product | May 19, 2014 | Issued |
Array
(
[id] => 9799651
[patent_doc_number] => 20150011595
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-08
[patent_title] => 'Inhibitors of Cholesterol Ester Transfer Protein'
[patent_app_type] => utility
[patent_app_number] => 14/271114
[patent_app_country] => US
[patent_app_date] => 2014-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13004
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14271114
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/271114 | Inhibitors of cholesterol ester transfer protein | May 5, 2014 | Issued |
Array
(
[id] => 9720219
[patent_doc_number] => 20140255920
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-11
[patent_title] => 'RHODAMINE COMPOUNDS AND THEIR USE AS FLUORESCENT LABELS'
[patent_app_type] => utility
[patent_app_number] => 14/268690
[patent_app_country] => US
[patent_app_date] => 2014-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 16065
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14268690
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/268690 | Rhodamine compounds and their use as fluorescent labels | May 1, 2014 | Issued |
Array
(
[id] => 11283728
[patent_doc_number] => 09499572
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-22
[patent_title] => 'Phosphatidylalkanols and compositions thereof'
[patent_app_type] => utility
[patent_app_number] => 14/888802
[patent_app_country] => US
[patent_app_date] => 2014-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15550
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14888802
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/888802 | Phosphatidylalkanols and compositions thereof | Apr 29, 2014 | Issued |
Array
(
[id] => 10122457
[patent_doc_number] => 09156806
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-10-13
[patent_title] => 'Process for purifying crude furan 2,5-dicarboxylic acid using hydrogenation'
[patent_app_type] => utility
[patent_app_number] => 14/259754
[patent_app_country] => US
[patent_app_date] => 2014-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 18149
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14259754
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/259754 | Process for purifying crude furan 2,5-dicarboxylic acid using hydrogenation | Apr 22, 2014 | Issued |
Array
(
[id] => 11463791
[patent_doc_number] => 09580408
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-02-28
[patent_title] => 'Polymorphic forms of nilotinib hydrochloride'
[patent_app_type] => utility
[patent_app_number] => 14/786902
[patent_app_country] => US
[patent_app_date] => 2014-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7895
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14786902
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/786902 | Polymorphic forms of nilotinib hydrochloride | Apr 22, 2014 | Issued |
Array
(
[id] => 9643555
[patent_doc_number] => 20140221667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-07
[patent_title] => 'FACTOR VIIA INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 14/250936
[patent_app_country] => US
[patent_app_date] => 2014-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19798
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14250936
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/250936 | Factor VIIa inhibitor | Apr 10, 2014 | Issued |
Array
(
[id] => 11276935
[patent_doc_number] => 09493409
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-15
[patent_title] => 'Process for the synthesis of 1-(2-((2,4-dimethylphenyl)thio)phenyl)piperazine'
[patent_app_type] => utility
[patent_app_number] => 14/781716
[patent_app_country] => US
[patent_app_date] => 2014-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4459
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14781716
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/781716 | Process for the synthesis of 1-(2-((2,4-dimethylphenyl)thio)phenyl)piperazine | Apr 3, 2014 | Issued |
Array
(
[id] => 9643229
[patent_doc_number] => 20140221342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-07
[patent_title] => '6-SUBSTITUTED PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 14/231356
[patent_app_country] => US
[patent_app_date] => 2014-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67631
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14231356
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/231356 | 6-substituted phenoxychroman carboxylic acid derivatives | Mar 30, 2014 | Issued |
Array
(
[id] => 11047505
[patent_doc_number] => 20160244462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-25
[patent_title] => '6-NITRO-2,3-DIHYDROIMIDAZO[2,1-b]OXAZOLES AND A PROCESS FOR THE PREPARATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/027137
[patent_app_country] => US
[patent_app_date] => 2014-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 28050
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15027137
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/027137 | 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles and a process for the preparation thereof | Mar 30, 2014 | Issued |
Array
(
[id] => 11684879
[patent_doc_number] => 09682913
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-20
[patent_title] => 'Method for improving optical purity of 2-hydroxycarboxylic acid or derivative thereof'
[patent_app_type] => utility
[patent_app_number] => 14/780625
[patent_app_country] => US
[patent_app_date] => 2014-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5968
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14780625
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/780625 | Method for improving optical purity of 2-hydroxycarboxylic acid or derivative thereof | Mar 27, 2014 | Issued |
Array
(
[id] => 10706751
[patent_doc_number] => 20160052899
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-25
[patent_title] => 'METHOD FOR PRODUCING ETHYLENE OXIDE'
[patent_app_type] => utility
[patent_app_number] => 14/781155
[patent_app_country] => US
[patent_app_date] => 2014-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6051
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14781155
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/781155 | Method for producing ethylene oxide | Mar 27, 2014 | Issued |
Array
(
[id] => 11319298
[patent_doc_number] => 09518036
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-13
[patent_title] => 'Method for producing ethylene oxide'
[patent_app_type] => utility
[patent_app_number] => 14/781245
[patent_app_country] => US
[patent_app_date] => 2014-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6751
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 258
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14781245
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/781245 | Method for producing ethylene oxide | Mar 27, 2014 | Issued |
Array
(
[id] => 9739280
[patent_doc_number] => 20140274999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'CEPHALOSPORIN COMPOSITIONS AND METHODS OF MANUFACTURE'
[patent_app_type] => utility
[patent_app_number] => 14/211465
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 4158
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14211465
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/211465 | CEPHALOSPORIN COMPOSITIONS AND METHODS OF MANUFACTURE | Mar 13, 2014 | Abandoned |
Array
(
[id] => 11217822
[patent_doc_number] => 09446141
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-20
[patent_title] => 'Methods of producing cancer compounds'
[patent_app_type] => utility
[patent_app_number] => 14/776730
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 3
[patent_no_of_words] => 5405
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14776730
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/776730 | Methods of producing cancer compounds | Mar 13, 2014 | Issued |
Array
(
[id] => 10888222
[patent_doc_number] => 08912219
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-16
[patent_title] => 'Aryl sulfamide and sulfamate derivatives as RORc modulators'
[patent_app_type] => utility
[patent_app_number] => 14/210978
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22231
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14210978
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/210978 | Aryl sulfamide and sulfamate derivatives as RORc modulators | Mar 13, 2014 | Issued |
Array
(
[id] => 11480446
[patent_doc_number] => 09586975
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-03-07
[patent_title] => 'Macrocyclic salt-inducible kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/776798
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34346
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14776798
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/776798 | Macrocyclic salt-inducible kinase inhibitors | Mar 13, 2014 | Issued |